Quick Answer
NewGenIvf Group Ltd reported Cash and Equivalents of $758.6 thousand for fiscal year 2025.
NewGenIvf Group Ltd Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $758.6K | +65.7% |
| 2024 | $457.7K | +746.0% |
| 2023 | $54.1K | +96.3% |
| 2022 | $27.6K | — |
- NewGenIvf Group Ltd showed an increase of +65.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2025 period, NewGenIvf Group Ltd’s cash and equivalents has grown by 2653.0% (from $27.6 thousand to $758.6 thousand).
- The most recent figure is from NewGenIvf Group Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: